Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.

Accurately determining a company’s long-term prospects isn’t easy, especially when sentiment is weak. That’s where StockStory comes in - to help you find attractive investment candidates backed by unbiased research. That said, here are three stocks where the outlook is warranted and some alternatives with better fundamentals.

Integra LifeSciences (IART)

Consensus Price Target: $17.43 (-7.3% implied return)

Founded in 1989 as a pioneer in regenerative medicine technology, Integra LifeSciences (NASDAQ: IART) develops and manufactures medical technologies for neurosurgery, wound care, and surgical reconstruction, including regenerative tissue products and surgical instruments.

Why Is IART Risky?

1. Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
2. Incremental sales over the last five years were much less profitable as its earnings per share fell by 2.4% annually while its revenue grew
3. High net-debt-to-EBITDA ratio of 5× increases the risk of forced asset sales or dilutive financing if operational performance weakens

At $18.80 per share, Integra LifeSciences trades at 7.3x forward P/E. To fully understand why you should be careful with IART, check out our full research report (it’s free).

Hamilton Insurance Group (HG)

Consensus Price Target: $34.14 (1.8% implied return)

Founded in 2013 and operating through three distinct underwriting platforms across four countries, Hamilton Insurance Group (NYSE: HG) operates global specialty insurance and reinsurance platforms across Lloyd's, Ireland, Bermuda, and the United States.

Why Does HG Give Us Pause?

1. Sales are projected to remain flat over the next 12 months as demand decelerates from its two-year trend
2. Performance over the past two years shows its incremental sales were less profitable, as its 14% annual earnings per share growth trailed its revenue gains

Hamilton Insurance Group is trading at $33.54 per share, or 1.1x forward P/B. Dive into our free research report to see why there are better opportunities than HG.

Columbia Financial (CLBK)

Consensus Price Target: $19 (-9% implied return)

Founded during the Roaring Twenties in 1926 and headquartered in Fair Lawn, New Jersey, Columbia Financial (NASDAQ: CLBK) operates federally chartered savings banks in New Jersey that offer traditional banking services including loans, deposits, and insurance products.

Why Are We Out on CLBK?

1. Loans are facing end-market challenges during this cycle, as seen in its flat net interest income over the last five years
2. Net interest margin of 2.1% is well below other banks, signaling its loans aren’t very profitable
3. Sales over the last five years were less profitable as its earnings per share fell by 3.8% annually while its revenue was flat

Columbia Financial’s stock price of $20.87 implies a valuation ratio of 1.7x forward P/B. Check out our free in-depth research report to learn more about why CLBK doesn’t pass our bar.

Stocks We Like More

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.